Cargando…
Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances
Indomethacin (IND) is a drug which after successful clinical trials became available for general prescription in 1965 and from that time is one of the most widely used anti-inflammatory drug with the highest potencies in the in vitro and in vivo models. However, despite its high therapeutic efficacy...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998224/ https://www.ncbi.nlm.nih.gov/pubmed/33809343 http://dx.doi.org/10.3390/molecules26061576 |